CSF3R and neutropenia: Other biological inhibitors for degradation have been identified including methyl-β-cyclodextrin, hyperosmotic sucrose, severely reduced internalization-defective GCSFR mutants like D715, and GCSFR deletion mutations, which are often found in patients with neutropenia.